Vertex's non-opioid drug succeeds in back pain trial (NASDAQ:VRTX) | Seeking Alpha

Vertex Pharmaceuticals' suzetrigine shows promising results in treating painful lumbosacral radiculopathy, but stock falls due to placebo …
Source: back pain

Leave a Reply

Your email address will not be published. Required fields are marked *